A novel action of Alzheimer's amyloid β-protein (Aβ): Oligomeric Aβ promotes lipid release

Journal of Neuroscience

Volumn 21, Issue 18, 2001, Pages 7226-7235

  Michikawa, Makoto ^a   Gong, Jian Sheng ^a   Fan, Qi Wen ^a   Sawamura, Naoya ^a   Yanagisawa, Katsuhiko ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Alzheimer's disease; Amyloid protein; Cholesterol release; Cultured neurons; High density lipoprotein; Phospholipid

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; AMYLOID BETA PROTEIN; CHOLESTEROL; CONGO RED; HIGH DENSITY LIPOPROTEIN; MONOSIALOGANGLIOSIDE; OLIGOMER; PHOSPHOLIPID; PROTEIN KINASE INHIBITOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; EMBRYO; HOMEOSTASIS; INTERNALIZATION; LIPID METABOLISM; NERVE CELL; NERVE CELL MEMBRANE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0035884905     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.21-18-07226.2001     Document Type: Article

References (54)

1. Lipid binding to amyloid β-peptide aggregates: Preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids
2. Amyloid β-peptide is transported on lipoproteins and albumin in human plasma
3. Acceleration of amyloid fibril formation by specific binding of Aβ(1-40) peptide to ganglioside-containing membrane vesicles
4. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation
5. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
6. Lipid polymorphism and protein-lipid interactions
7. Aging and dementia
8. Unique lipoproteins secreted by primary astrocytes from wild type, apoE (-/-), and human apoE transgenic mice
9. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype
10. Cholesterol-dependent modulation of tau phosphorylation in cultured neurons
11. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons
12. Inhibition of the electrostatic interaction between β-amyloid peptide and membranes prevents β-amyloid-induced toxicity
13. Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease
14. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
15. Enhancement of MTT, a tetrazolium salt, exocytosis by amyloid β-protein and chloroquine in cultured rat astrocytes
16. A possible model of senile plaques using synthetic amyloid β-protein and rat glial culture
17. Differential generation of high-density lipoprotein by endogenous and exogenous apolipoproteins in cultured fetal rat astrocytes
18. Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies
19. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma
20. Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: Association with high density lipoproteins
21. Nascent astrocyte particles differ from lipoproteins in CSF
22. Soluble multimeric Alzheimer beta(1-40) preamyloid complexes in dilute solution
23. Quantification of beta-sheet amyloid fibril structures with thioflavin T
24. Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat vascular smooth muscle cells
25. Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis
26. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red
27. Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease
28. Alzheimer's disease amyloid β-peptide 25-35 is localized in the membrane hydrocarbon core: X-ray diffraction analysis
29. Distribution and fluidizing action of soluble and aggregated amyloid β-peptide in rat synaptic plasma membranes
30. Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome
31. Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF
32. Membrane disruption by Alzheimer β-amyloid peptides mediated through specific binding to either phospholipids or gangliosides. Implications for neurotoxicity
33. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion
34. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol
35. Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis
36. Apolipoprotein E exhibits isoform-specific promotion of lipid efflux from astrocytes and neurons in culture
37. β-Amyloid peptide decreases membrane fluidity
38. A synthetic amphiphilic β-strand tridecapeptide: A model for apolipoprotein B
39. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state
40. Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy
41. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture
42. Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red
43. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
44. Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice
45. Amyloid peptides are toxic via a common oxidative mechanism
46. Alzheimer's disease: A central role for amyloid
47. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
48. High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy
49. Self-association of β-amyloid peptide (1-40) in solution and binding to lipid membranes
50. Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation
51. Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate
52. Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins
53. GM1 ganglioside-bound amyloid β-protein (Aβ): A possible form of preamyloid in Alzheimer's disease